Process View
A series of reactions that takes place outside the cell that occur as a result of by-products of tissue damage, including collagen, cartilage, and basement membrane. The ultimate product of the kinin cascade include kallidin and bradykinin, agents known to induce smooth muscle contraction, vasoconstriction, and increased vascular permeability.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "kinin cascade"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 1.000 | ||
| PLAUR | plasminogen activator, urokinase receptor | 1.000 | ||
| PLAT | plasminogen activator, tissue | 0.986 | Human | |
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.983 | ||
| PLAU | plasminogen activator, urokinase | 0.969 | Human | |
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.856 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.734 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.506 | ||
| KNG1 | kininogen 1 | 0.303 | ||
| IL8 | interleukin 8 | 0.259 | ||
| TNC | tenascin C | 0.246 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.234 | ||
| NPC2 | Niemann-Pick disease, type C2 | 0.215 | ||
| IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.192 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.182 | ||
| SPHK1 | sphingosine kinase 1 | 0.153 | ||
| ORM1 | orosomucoid 1 | 0.103 | ||
| PLG | plasminogen | 0.102 | Human | |
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.095 | ||
| C8A | complement component 8, alpha polypeptide | 0.085 | ||
| FOSL1 | FOS-like antigen 1 | 0.084 | ||
| EMP1 | epithelial membrane protein 1 | 0.080 | ||
| FGB | fibrinogen beta chain | 0.077 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.075 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.073 | ||
| VTN | vitronectin | 0.072 | ||
| GCGR | glucagon receptor | 0.063 | ||
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.056 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.051 | ||
| LPA | lipoprotein, Lp(a) | 0.051 | Human | |
| AMT | aminomethyltransferase | 0.051 | ||
| PDGFC | platelet derived growth factor C | 0.051 | ||
| C9 | complement component 9 | 0.050 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.050 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.048 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.043 | ||
| INHBA | inhibin, beta A | 0.042 | ||
| THBS1 | thrombospondin 1 | 0.042 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.042 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.042 | ||
| CRP | C-reactive protein, pentraxin-related | 0.041 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.041 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.041 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.040 | ||
| TFR2 | transferrin receptor 2 | 0.040 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.039 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.038 | ||
| ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.038 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.037 | ||
| C4BPB | complement component 4 binding protein, beta | 0.035 | ||
| F2 | coagulation factor II (thrombin) | 0.034 | ||
| PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 0.034 | ||
| OSMR | oncostatin M receptor | 0.031 | ||
| PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 0.030 | ||
| FTCD | formiminotransferase cyclodeaminase | 0.030 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.029 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.029 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.027 | ||
| LIPC | lipase, hepatic | 0.027 | ||
| HPX | hemopexin | 0.026 | ||
| APOF | apolipoprotein F | 0.026 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.026 | ||
| SAA4 | serum amyloid A4, constitutive | 0.026 | ||
| F11 | coagulation factor XI | 0.025 | ||
| SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 | 0.024 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.024 | ||
| AGXT | alanine-glyoxylate aminotransferase | 0.024 | ||
| HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.023 | ||
| GJB1 | gap junction protein, beta 1, 32kDa | 0.022 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.022 | ||
| S100A2 | S100 calcium binding protein A2 | 0.021 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.020 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.020 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.020 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.019 | ||
| PVR | poliovirus receptor | 0.019 | ||
| TUBB6 | tubulin, beta 6 | 0.019 | ||
| ECM1 | extracellular matrix protein 1 | 0.019 | ||
| IL1B | interleukin 1, beta | 0.018 | ||
| C8B | complement component 8, beta polypeptide | 0.018 | ||
| EPHA2 | EPH receptor A2 | 0.018 | ||
| RANBP9 | RAN binding protein 9 | 0.017 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.017 | ||
| GBA3 | glucosidase, beta, acid 3 (cytosolic) | 0.017 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.016 | ||
| HABP2 | hyaluronan binding protein 2 | 0.016 | Human | |
| F10 | coagulation factor X | 0.016 | ||
| TTR | transthyretin | 0.016 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.015 | ||
| CHST11 | carbohydrate (chondroitin 4) sulfotransferase 11 | 0.015 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.015 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.015 | ||
| PDLIM4 | PDZ and LIM domain 4 | 0.015 | ||
| FAP | fibroblast activation protein, alpha | 0.015 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.015 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.014 | ||
| LTA4H | leukotriene A4 hydrolase | 0.014 | ||
| PROCR | protein C receptor, endothelial | 0.014 | ||
| GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.013 | ||
| RAB17 | RAB17, member RAS oncogene family | 0.013 | ||
| FGA | fibrinogen alpha chain | 0.013 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.013 | ||
| LAMB3 | laminin, beta 3 | 0.013 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.013 | ||
| ALB | albumin | 0.013 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.013 | ||
| C8G | complement component 8, gamma polypeptide | 0.012 | ||
| PON3 | paraoxonase 3 | 0.012 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.012 | ||
| HRG | histidine-rich glycoprotein | 0.012 | ||
| TMEM158 | transmembrane protein 158 (gene/pseudogene) | 0.012 | ||
| SLC6A12 | solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | 0.012 | ||
| TM4SF5 | transmembrane 4 L six family member 5 | 0.012 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.012 | ||
| APCS | amyloid P component, serum | 0.012 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.012 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.012 | ||
| FN1 | fibronectin 1 | 0.011 | ||
| SERPINB8 | serpin peptidase inhibitor, clade B (ovalbumin), member 8 | 0.011 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.011 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.011 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.011 | ||
| CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.011 | ||
| VEGFC | vascular endothelial growth factor C | 0.011 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.011 | ||
| NRP2 | neuropilin 2 | 0.010 | ||
| LGALS4 | lectin, galactoside-binding, soluble, 4 | 0.010 | ||
| RAB26 | RAB26, member RAS oncogene family | 0.010 | ||
| SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.010 | ||
| EHD4 | EH-domain containing 4 | 0.010 | ||
| C6 | complement component 6 | 0.010 | ||
| HEXB | hexosaminidase B (beta polypeptide) | 0.010 |